Dermoscopy vs Standard Marking for the Completeness of Excision of Keratinocyte Skin Cancers: The ClearMark Trial

Clinical trial NCT06627036 · RECRUITING

Trial details

NCT number: NCT06627036
Sponsor: Hull University Teaching Hospitals NHS Trust
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Keratinocyte Skin Cancer

Start date: 2024-11-21
Primary completion: 2026-05-31
Enrollment: 1376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.